Skip to main
CAH

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health (CAH) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Cardinal Health is a well-established leader in the US pharmaceutical wholesale industry, with diverse revenue streams, a strong competitive advantage, and a focus on higher-value services. Despite potential risks in the industry, the company's strategic investments and strong leadership position them for continued success. With a strong distribution network and partnerships, accompanied by new automation technologies and a growing demand for specialty drugs, Cardinal Health is poised for growth and success in the pharmaceutical market.

Bears say

Cardinal Health is facing pressure from increasing competition, as well as potential reimbursement pressures and regulatory changes in the healthcare industry. Additionally, the company's debt levels and acquisition strategies could also be a cause for concern. Overall, while Cardinal Health has strong potential for growth, there are some fundamental risks that could impact its performance in the near future.

Cardinal Health (CAH) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardinal Health (CAH) Forecast

Analysts have given Cardinal Health (CAH) a Buy based on their latest research and market trends.

According to 11 analysts, Cardinal Health (CAH) has a Buy consensus rating as of Jun 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $231.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $231.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardinal Health (CAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.